Invention Grant
- Patent Title: Proteasome activity enhancing compounds
-
Application No.: US17133362Application Date: 2020-12-23
-
Publication No.: US11746098B2Publication Date: 2023-09-05
- Inventor: Matthew Cullen , Sheila Hauck , Megan Foley , Bradley Tait , Markus Haeberlein
- Applicant: Proteostasis Therapeutics, Inc.
- Applicant Address: US MA Boston
- Assignee: Proteostasis Therapeutics, Inc.
- Current Assignee: Proteostasis Therapeutics, Inc.
- Current Assignee Address: US MA Boston
- Agency: Armstrong Teasdale LLP
- Main IPC: C07D401/06
- IPC: C07D401/06 ; C07D207/333 ; C07D207/335 ; C07D403/06 ; C07D403/12 ; C07D403/14 ; C07D405/12
Abstract:
The present invention is directed to compounds that inhibit Usp14, compositions thereof, and methods for the treatment of a condition associated with a dysfunction in proteostasis.
Public/Granted literature
- US20210188802A1 PROTEASOME ACTIVITY ENHANCING COMPOUNDS Public/Granted day:2021-06-24
Information query
